The controversial pediatric review voucher program will survive another three months following President Barack Obama's signature of a short-term stopgap bill Friday (Sept. 30). That reauthorization comes just one day after FDA announced they were cutting pediatric voucher user fees by over $20,000 starting Oct. 1. One industry source previously told Inside Health Policy that the user fees should defray the costs of the pediatric voucher review program, which have been a concern for the agency. The rare pediatric...